Related Experiment Video
Updated: May 22, 2026

09:50
Enhanced Photoluminescence of Curcuma longa Extracts via Chitosan-Mediated Energy Transfer for Textile Authentication Applications
Published on: December 22, 2023
Curcumin and curcuminoids in quest for medicinal status
Grzegorz Grynkiewicz1, Piotr Ślifirski
1Pharmaceutical Research Institute, Warszawa, Poland. g.grynkiewicz@ifarm.eu
Acta Biochimica Polonica
|May 17, 2012
Summary
Curcumin shows therapeutic potential, interacting with many molecular targets. However, its drug development is hindered by poor absorption, distribution, metabolism, and excretion (ADME) properties.
Area of Science:
- Pharmacology and Medicinal Chemistry
- Natural Product Drug Discovery
Background:
- Curcumin, a compound from turmeric, has a long history in Ayurvedic medicine and Asian cuisine.
- It is being investigated as a drug candidate due to its potential therapeutic applications.
- Curcumin's chemical structure, with a conjugated double bond system, contributes to its high reactivity and interaction with numerous molecular targets.
Purpose of the Study:
- To evaluate the therapeutic potential of curcumin as a drug candidate.
- To analyze the molecular interactions and pharmacological properties of curcumin.
- To identify limitations in curcumin's drug-like properties, specifically in ADME.
Main Methods:
- Review of preclinical pharmacological data.
- Analysis of spectral, physicochemical, and biological experimental observations.
- Assessment of curcumin's interactions with molecular targets.
Main Results:
- Preclinical data support the traditional medicinal uses of curcumin.
- Curcumin interacts with a wide range of molecular targets.
- Suboptimal properties in absorption, distribution, metabolism, and excretion (ADME) were identified.
Conclusions:
- Curcumin demonstrates significant therapeutic promise based on its interactions with multiple targets.
- Further research is needed to overcome the ADME limitations for effective drug development.
- Curcumin and its congeners require optimization for improved pharmacokinetic profiles.
